ConductScience.org, home

Paper · 6973604

Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity.

Granelli-Piperno A and 2 others. J Exp Med, 1981. Cited by 53 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity. Papers, record 6973604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6973604

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity.
PubMed
Journal
J Exp Med
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
1.39
iCite
Revised in PubMed
2019-05-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Granelli-Piperno AA
2Vassalli JDJ D
3Reich EE

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-2Major topic
LymphokinesMajor topic
Animals
Chromatography, Ion Exchange
Dose-Response Relationship, Immunologic
Electrophoresis, Polyacrylamide Gel
Lymphocyte Activation
Mice
Mice, Inbred BALB C
Mice, Nude
Sodium Dodecyl Sulfate

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA-08290NCI NIH HHSUnited StatesPubMed
GM-07245NIGMS NIH HHSUnited StatesPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,034,749Immunization of dissociated spleen cell cultures from normal mice.J Exp Med1967https://conductscience.org/library/papers/6034749PubMed
26,450,803Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation.J Immunol1981https://conductscience.org/library/papers/6450803PubMed
34,592,599Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures.J Immunol1974https://conductscience.org/library/papers/4592599PubMed
4942,051A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem1976https://conductscience.org/library/papers/942051PubMed
5833,546Macrophage plasminogen activator: induction by products of activated lymphoid cells.J Exp Med1977https://conductscience.org/library/papers/833546PubMed
6303,772Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s).Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/303772PubMed
7145,543Long term culture of tumour-specific cytotoxic T cells.Nature1977https://conductscience.org/library/papers/145543PubMed
8310,827The purification and quantitation of helper T cell-replacing factors secreted by murine spleen cells activated by concanavalin A.J Immunol1979https://conductscience.org/library/papers/310827PubMed
9109,511Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes.J Immunol1979https://conductscience.org/library/papers/109511PubMed
10312,860Physicochemical characterization of lymphocyte-activating factor (LAF).J Immunol1979https://conductscience.org/library/papers/312860PubMed

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
6,980,256Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.J Exp Med1982https://conductscience.org/library/papers/6980256PubMed
6,608,103Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6608103PubMed
6,607,316Cytotoxic T cells both produce and respond to interleukin 2.J Exp Med1984https://conductscience.org/library/papers/6607316PubMed
6,601,512Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations. Preliminary report.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6601512PubMed
6,417,263Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.J Exp Med1983https://conductscience.org/library/papers/6417263PubMed
6,376,356In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.Infect Immun1984https://conductscience.org/library/papers/6376356PubMed
6,334,715Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A.J Exp Med1984https://conductscience.org/library/papers/6334715PubMed
6,300,278Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation.J Exp Med1983https://conductscience.org/library/papers/6300278PubMed
6,236,276Antibodies to interleukin 2. Effects on immune responses in vitro and in vivo.J Exp Med1984https://conductscience.org/library/papers/6236276PubMed
6,228,520Suppressor cells induced by BCG release non-specific factors in vitro which inhibit DNA synthesis and interleukin-2 production.Immunology1984https://conductscience.org/library/papers/6228520PubMed

1 to 10 of 16

See all 16 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6973604

GET https://conductscience.org/api/papers/v1/6973604/authors